Sequencing of systemic therapies in advanced NSCLC with MET exon 14 skipping mutation: A multicenter experience.

S. Lau,Kirstin Perdrizet,Danilo Giffoni de Mello Morais Mata,Andrea S Fung,Geoffrey Liu,Penelope A. Bradbury,Frances A. Shepherd,Adrian G. Sacher,Brandon S. Sheffield,David M. Hwang,Ming-Sound Tsao,Susanna Y. Cheng,Parneet Cheema,Natasha B. Leighl

Sequencing of systemic therapies in advanced NSCLC with MET exon 14 skipping mutation: A multicenter experience.

2021

S. Lau
Kirstin Perdrizet
Danilo Giffoni de Mello Morais Mata
Andrea S Fung
Geoffrey Liu
Penelope A. Bradbury
Frances A. Shepherd
Adrian G. Sacher
Brandon S. Sheffield
David M. Hwang
Ming-Sound Tsao
Susanna Y. Cheng
Parneet Cheema
Natasha B. Leighl

e21123Background: The treatment landscape for patients with metastatic non-small cell lung cancer (mNSCLC) with a MET exon 14 skipping mutation (MET ex14) is rapidly changing, with recent approvals...

Keywords:

Oncology
non small cell
Internal medicine
Medicine
MET Exon 14 Skipping Mutation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations